Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
10.1M
-
Shares change
-
+201K
-
Total reported value, excl. options
-
$185M
-
Value change
-
+$3.82M
-
Number of buys
-
9
-
Number of sells
-
-10
-
Price
-
$18.32
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2015
29 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2015.
Ascendis Pharma A/S - ADR (ASND) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.1M shares
of 55.6M outstanding shares and own 18.16% of the company stock.
Largest 10 shareholders include FMR LLC (2.31M shares), RA CAPITAL MANAGEMENT, LLC (1.67M shares), Visium Asset Management, LP (1.37M shares), RS INVESTMENT MANAGEMENT CO LLC (979K shares), VHCP Management II, LLC (721K shares), JANUS CAPITAL MANAGEMENT LLC (702K shares), ACUTA CAPITAL PARTNERS, LLC (519K shares), BAKER BROS. ADVISORS LP (506K shares), Sio Capital Management, LLC (285K shares), and Rock Springs Capital Management LP (270K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.